Stopping infliximab in crohn's disease: Still an ongoing STORI

Inflammatory Bowel Diseases

Volumn 18, Issue 11, 2012, Pages 2201-2202

  Peyrin Biroulet, Laurent ^a   Danese, Silvio ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE;

CROHN DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; NOTE; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

EID: 84867580636     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.23016     Document Type: Note

References (7)

1. Louis E, Mary JY, Vernier-Massouille G, et al. Maintenance of remission among patients with Crohn's disease on anti-metabolite therapy after infliximab therapy is stopped. Gastroenterology. 2012; 142: 63-70.
2. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010; 362: 1383-1395.
3. Danese S, Colombel JF, Reinisch W, et al. Review article: infliximab for Crohn's disease treatment-shifting therapeutic strategies after 10 years of clinical experience. Aliment Pharmacol Ther. 2011; 33: 857-869.
4. Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012; 61: 241-247.
5. Mariette X, Matucci-Cerinic M, Pavelka K, et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis. 2011; 70: 1895-1904.
6. Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology. 2011; 141: 1621-1628.
7. Kavanaugh A,. Economic issues with new rheumatologic therapeutics. Curr Opin Rheumatol. 2007; 19: 272-276.